- Student Records
Programme & Unit Catalogues


PA40157: The molecular biology and treatment of cancer

Follow this link for further information on academic years Academic Year: 2012/3
Follow this link for further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Follow this link for further information on credits Credits: 6
Follow this link for further information on unit levels Level: Masters UG & PG (FHEQ level 7)
Follow this link for further information on period slots Period: Semester 2
Follow this link for further information on unit assessment Assessment: EX 100%
Follow this link for further information on supplementary assessment Supplementary Assessment: Like-for-like reassessment (where allowed by programme regulations)
Follow this link for further information on unit rules Requisites: Before taking this unit you must take PA20241
Follow this link for further information on unit content Description: Aims:
To familiarise the student with recent advances in molecular and cellular processes underlying tumour development and its treatment.

Learning Outcomes:
On successful completion of this unit, the student should be able to demonstrate an in-depth knowledge and understanding of the disease process in cancer and the complexity of its treatment, to evaluate critically this knowledge in order to resolve conflicting issues and thus identify and analyse rational treatment protocols.

Skills:
Scientific skills (T/F/A)
Study skills, handling information, working with others (T/F)
Problem solving (T/F)

Content:
Epidemiological studies of cancer and a recognition of how this approach retains validity. Chemical mutagenesis. Cell biology of tumour development including apoptosis, oncogenes and tumour suppressor genes. The molecular mechanisms of action of the major classes of drugs currently in use and their shortcomings. Active and passive immunotherapy. Then either the clinical or research setting; palliative or curative treatment, relationship to surgery, chemotherapy or radiotherapy, risk-benefit analysis. CRM Guidelines on safe handling of cytotoxic agents.
Follow this link for further information on programme availabilityProgramme availability:

PA40157 is a Designated Essential Unit on the following programmes:

Department of Pharmacy & Pharmacology

PA40157 is Optional on the following programmes:

Department of Biology & Biochemistry
  • USBB-ANM02 : MBiochem (hons) Biochemistry (Full-time with Thin Sandwich Placements) - Year 4
Programmes in Natural Sciences
  • UXXX-AFM01 : MSci (hons) Natural Sciences (Full-time) - Year 4
  • UXXX-AKM02 : MSci (hons) Natural Sciences with Professional Placement (Full-time with Thick Sandwich Placement) - Year 5
  • UXXX-AAM02 : MSci (hons) Natural Sciences with Study Year Abroad (Full-time with Study Year Abroad) - Year 5
Department of Pharmacy & Pharmacology
  • USPA-AKM02 : MPharmacology (hons) (Full-time with Thick Sandwich Placement) - Year 4

Notes:
* This unit catalogue is applicable for the 2012/13 academic year only. Students continuing their studies into 2013/14 and beyond should not assume that this unit will be available in future years in the format displayed here for 2012/13.
* Programmes and units are subject to change at any time, in accordance with normal University procedures.
* Availability of units will be subject to constraints such as staff availability, minimum and maximum group sizes, and timetabling factors as well as a student's ability to meet any pre-requisite rules.